You just read:

Late-Breaking REDUCE Trial Data Demonstrate Non-inferiority of 3 vs 12 Months Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Treated With the COMBO[TM] Stent

News provided by

OrbusNeich

01 Nov, 2017, 18:10 GMT